Philip Kantoff

Philip Wayne Kantoff is the founder of Convergent Therapeutics, Inc. Current positions include Chairman-Global Treatment Science Network at Prostate Cancer Foundation, Independent Director at Context Therapeutics LLC since 2019, and Independent Director at Context Therapeutics, Inc. since 2018.
Former roles include Chairman-Medicine Department at Memorial Sloan Kettering Cancer Center, Director-Lake Center for Genitourinary Oncology at Dana-Farber Cancer Institute, Inc. from 1989 to 2015, Director at Lank Center For Genitourinary Oncology, Independent Director at ESSA Pharma, Inc. from 2022 to 2025, Medicine Professor at Harvard University, Principal at National Institutes of Health, and Professor Emeritus-Medicine at Harvard Medical School.
Education includes a doctorate from Brown University conferred in 1979.